Literature DB >> 2592558

Genetic and environmental factors that regulate cytosolic epoxide hydrolase activity in normal human lymphocytes.

K K Norris1, T M DeAngelo, E S Vesell.   

Abstract

To determine whether genetic mechanisms control large variations in cytosolic epoxide hydrolase (cEH) activity of unstimulated lymphocytes from normal human subjects, cEH activity was measured in (a) 6 sets of monozygotic (MZ) twins and 6 sets of dizygotic (DZ) twins; (b) 100 unrelated male subjects; and (c) 6 families. The twin study revealed predominantly genetic control (H2(1) = 0.95). Variability was markedly less within MZ (intrapair variance = 0.25) than DZ twins (intrapair variance = 6.33). In 100 unrelated male subjects the extent of interindividual variation was 11-fold. Unimodal distribution of values among 99 subjects encompassed a sixfold range. One outlier with very high activity clearly stood apart. Using the whole distribution curve we phenotyped members of six families. In the outlier's family, analysis of three generations suggested autosomal dominant transmission of high cEH activity. Analysis of the other 5 families and of 12 sets of twins, all from the large unimodal distribution, was consistent with either monogenic or polygenic control of variations within this mode. Several temporal host factors, including fever, the menstrual cycle, a 24-h fast, and diurnal variations, were investigated. Fever and fasting elevated cEH activity. Diurnal variations produced no observable alteration. During the menstrual cycle irregular fluctuations occurred.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2592558      PMCID: PMC304051          DOI: 10.1172/JCI114358

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

Review 1.  Assessment of methods to identify sources of interindividual pharmacokinetic variations.

Authors:  E S Vesell; M B Penno
Journal:  Clin Pharmacokinet       Date:  1983 Sep-Oct       Impact factor: 6.447

Review 2.  Drug detoxification: epoxide hydrolase.

Authors:  F Oesch
Journal:  Prog Clin Biol Res       Date:  1983

3.  Monogenic control of variations in antipyrine metabolite formation. New polymorphism of hepatic drug oxidation.

Authors:  M B Penno; E S Vesell
Journal:  J Clin Invest       Date:  1983-06       Impact factor: 14.808

4.  On the significance of host factors that affect drug disposition.

Authors:  E S Vesell
Journal:  Clin Pharmacol Ther       Date:  1982-01       Impact factor: 6.875

5.  Pharmacogenetics and the fetus.

Authors:  S P Spielberg
Journal:  N Engl J Med       Date:  1982-07-08       Impact factor: 91.245

6.  A rapid, sensitive method for detection of alkaline phosphatase-conjugated anti-antibody on Western blots.

Authors:  M S Blake; K H Johnston; G J Russell-Jones; E C Gotschlich
Journal:  Anal Biochem       Date:  1984-01       Impact factor: 3.365

7.  Radiometric assays for mammalian epoxide hydrolases and glutathione S-transferase.

Authors:  S S Gill; K Ota; B D Hammock
Journal:  Anal Biochem       Date:  1983-05       Impact factor: 3.365

8.  Measurement and characterization of membrane-bound and soluble epoxide hydrolase activities in resting mononuclear leukocytes from human blood.

Authors:  J Seidegård; J W DePierre; R W Pero
Journal:  Cancer Res       Date:  1984-09       Impact factor: 12.701

9.  Determination of epoxide hydrolase activity in whole cells (human lymphocytes) and activation by benzoflavones.

Authors:  H R Glatt; T Wölfel; F Oesch
Journal:  Biochem Biophys Res Commun       Date:  1983-01-27       Impact factor: 3.575

10.  Polymorphism of theophylline metabolism in man.

Authors:  C A Miller; L B Slusher; E S Vesell
Journal:  J Clin Invest       Date:  1985-05       Impact factor: 14.808

View more
  2 in total

Review 1.  Molecular basis of polymorphic drug metabolism.

Authors:  A K Daly
Journal:  J Mol Med (Berl)       Date:  1995-11       Impact factor: 4.599

2.  Soluble Epoxide Hydrolase Inhibition: Targeting Multiple Mechanisms of Ischemic Brain Injury with a Single Agent.

Authors:  Jeffrey J Iliff; Nabil J Alkayed
Journal:  Future Neurol       Date:  2009-03-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.